LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel ; Online: Design and implementation of a digital site-less clinical study of serial rapid antigen testing to identify asymptomatic SARS-CoV-2 infection.

    Soni, Apurv / Herbert, Carly / Pretz, Caitlin / Stamegna, Pamela / Filippaios, Andreas / Shi, Qiming / Suvarna, Thejas / Harman, Emma / Schrader, Summer / Nowak, Chris / Schramm, Eric / Kheterpal, Vik / Behar, Stephanie / Tarrant, Seanan / Ferranto, Julia / Hafer, Nathaniel / Robinson, Matthew / Achenbach, Chad / Murphy, Robert L /
    Manabe, Yukari C / Gibson, Laura / Barton, Bruce / O'Connor, Laurel / Fahey, Nisha / Orvek, Elizabeth / Lazar, Peter / Ayturk, Didem / Wong, Steven / Zai, Adrian / Cashman, Lisa / Rao, Lokinendi V / Luzuriaga, Katherine / Lemon, Stephenie / Blodgett, Allison / Trippe, Elizabeth / Barcus, Mary / Goldberg, Brittany / Roth, Kristian / Stenzel, Timothy / Heetderks, William / Broach, John / McManus, David

    Journal of clinical and translational science

    2023  Band 7, Heft 1, Seite(n) e120

    Abstract: Background: Rapid antigen detection tests (Ag-RDT) for SARS-CoV-2 with emergency use authorization generally include a condition of authorization to evaluate the test's performance in asymptomatic individuals when used serially. We aim to describe a ... ...

    Abstract Background: Rapid antigen detection tests (Ag-RDT) for SARS-CoV-2 with emergency use authorization generally include a condition of authorization to evaluate the test's performance in asymptomatic individuals when used serially. We aim to describe a novel study design that was used to generate regulatory-quality data to evaluate the serial use of Ag-RDT in detecting SARS-CoV-2 virus among asymptomatic individuals.
    Methods: This prospective cohort study used a siteless, digital approach to assess longitudinal performance of Ag-RDT. Individuals over 2 years old from across the USA with no reported COVID-19 symptoms in the 14 days prior to study enrollment were eligible to enroll in this study. Participants throughout the mainland USA were enrolled through a digital platform between October 18, 2021 and February 15, 2022. Participants were asked to test using Ag-RDT and molecular comparators every 48 hours for 15 days. Enrollment demographics, geographic distribution, and SARS-CoV-2 infection rates are reported.
    Key results: A total of 7361 participants enrolled in the study, and 492 participants tested positive for SARS-CoV-2, including 154 who were asymptomatic and tested negative to start the study. This exceeded the initial enrollment goals of 60 positive participants. We enrolled participants from 44 US states, and geographic distribution of participants shifted in accordance with the changing COVID-19 prevalence nationwide.
    Conclusions: The digital site-less approach employed in the "Test Us At Home" study enabled rapid, efficient, and rigorous evaluation of rapid diagnostics for COVID-19 and can be adapted across research disciplines to optimize study enrollment and accessibility.
    Sprache Englisch
    Erscheinungsdatum 2023-05-10
    Erscheinungsland England
    Dokumenttyp Journal Article
    ISSN 2059-8661
    ISSN (online) 2059-8661
    DOI 10.1017/cts.2023.540
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel: Finding a Needle in a Haystack: Design and Implementation of a Digital Site-less Clinical Study of Serial Rapid Antigen Testing to Identify Asymptomatic SARS-CoV-2 Infection.

    Soni, Apurv / Herbert, Carly / Pretz, Caitlin / Stamegna, Pamela / Filippaios, Andreas / Shi, Qiming / Suvarna, Thejas / Harman, Emma / Schrader, Summer / Nowak, Chris / Schramm, Eric / Kheterpal, Vik / Behar, Stephanie / Tarrant, Seanan / Ferranto, Julia / Hafer, Nathaniel / Robinson, Matthew / Achenbach, Chad / Murphy, Robert L /
    Manabe, Yukari C / Gibson, Laura / Barton, Bruce / O'Connor, Laurel / Fahey, Nisha / Orvek, Elizabeth / Lazar, Peter / Ayturk, Didem / Wong, Steven / Zai, Adrian / Cashman, Lisa / Rao, Lokinendi V / Luzuriaga, Katherine / Lemon, Stephenie / Blodgett, Allison / Trippe, Elizabeth / Barcus, Mary / Goldberg, Brittany / Roth, Kristian / Stenzel, Timothy / Heetderks, William / Broach, John / McManus, David

    medRxiv : the preprint server for health sciences

    2023  

    Abstract: Background: Rapid antigen tests (Ag-RDT) for SARS-CoV-2 with Emergency Use Authorization generally include a condition of authorization to evaluate the test's performance in asymptomatic individuals when used serially.: Objective: To describe a novel ...

    Abstract Background: Rapid antigen tests (Ag-RDT) for SARS-CoV-2 with Emergency Use Authorization generally include a condition of authorization to evaluate the test's performance in asymptomatic individuals when used serially.
    Objective: To describe a novel study design to generate regulatory-quality data to evaluate serial use of Ag-RDT in detecting SARS-CoV-2 virus among asymptomatic individuals.
    Design: Prospective cohort study using a decentralized approach. Participants were asked to test using Ag-RDT and molecular comparators every 48 hours for 15 days.
    Setting: Participants throughout the mainland United States were enrolled through a digital platform between October 18, 2021 and February 15, 2022. Ag-RDTs were completed at home, and molecular comparators were shipped to a central laboratory.
    Participants: Individuals over 2 years old from across the U.S. with no reported COVID-19 symptoms in the 14 days prior to study enrollment were eligible to enroll in this study.
    Measurements: Enrollment demographics, geographic distribution, and SARS-CoV-2 infection rates are reported.
    Key results: A total of 7,361 participants enrolled in the study, and 492 participants tested positive for SARS-CoV-2, including 154 who were asymptomatic and tested negative to start the study. This exceeded the initial enrollment goals of 60 positive participants. We enrolled participants from 44 U.S. states, and geographic distribution of participants shifted in accordance with the changing COVID-19 prevalence nationwide.
    Limitations: New, complex workflows required significant operational and data team support. Conclusions: The digital site-less approach employed in the 'Test Us At Home' study enabled rapid, efficient, and rigorous evaluation of rapid diagnostics for COVID-19, and can be adapted across research disciplines to optimize study enrollment and accessibility.
    Sprache Englisch
    Erscheinungsdatum 2023-01-23
    Erscheinungsland United States
    Dokumenttyp Preprint
    DOI 10.1101/2022.08.04.22278274
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: MaHPIC malaria systems biology data from Plasmodium cynomolgi sporozoite longitudinal infections in macaques.

    DeBarry, Jeremy D / Nural, Mustafa V / Pakala, Suman B / Nayak, Vishal / Warrenfeltz, Susanne / Humphrey, Jay / Lapp, Stacey A / Cabrera-Mora, Monica / Brito, Cristiana F A / Jiang, Jianlin / Saney, Celia L / Hankus, Allison / Stealey, Hannah M / DeBarry, Megan B / Lackman, Nicolas / Legall, Noah / Lee, Kevin / Tang, Yan / Gupta, Anuj /
    Trippe, Elizabeth D / Bridger, Robert R / Weatherly, Daniel Brent / Peterson, Mariko S / Jiang, Xuntian / Tran, ViLinh / Uppal, Karan / Fonseca, Luis L / Joyner, Chester J / Karpuzoglu, Ebru / Cordy, Regina J / Meyer, Esmeralda V S / Wells, Lance L / Ory, Daniel S / Lee, F Eun-Hyung / Tirouvanziam, Rabindra / Gutiérrez, Juan B / Ibegbu, Chris / Lamb, Tracey J / Pohl, Jan / Pruett, Sarah T / Jones, Dean P / Styczynski, Mark P / Voit, Eberhard O / Moreno, Alberto / Galinski, Mary R / Kissinger, Jessica C

    Scientific data

    2022  Band 9, Heft 1, Seite(n) 722

    Abstract: Plasmodium cynomolgi causes zoonotic malarial infections in Southeast Asia and this parasite species is important as a model for Plasmodium vivax and Plasmodium ovale. Each of these species produces hypnozoites in the liver, which can cause relapsing ... ...

    Abstract Plasmodium cynomolgi causes zoonotic malarial infections in Southeast Asia and this parasite species is important as a model for Plasmodium vivax and Plasmodium ovale. Each of these species produces hypnozoites in the liver, which can cause relapsing infections in the blood. Here we present methods and data generated from iterative longitudinal systems biology infection experiments designed and performed by the Malaria Host-Pathogen Interaction Center (MaHPIC) to delve deeper into the biology, pathogenesis, and immune responses of P. cynomolgi in the Macaca mulatta host. Infections were initiated by sporozoite inoculation. Blood and bone marrow samples were collected at defined timepoints for biological and computational experiments and integrative analyses revolving around primary illness, relapse illness, and subsequent disease and immune response patterns. Parasitological, clinical, haematological, immune response, and -omic datasets (transcriptomics, proteomics, metabolomics, and lipidomics) including metadata and computational results have been deposited in public repositories. The scope and depth of these datasets are unprecedented in studies of malaria, and they are projected to be a F.A.I.R., reliable data resource for decades.
    Mesh-Begriff(e) Animals ; Host-Pathogen Interactions ; Macaca mulatta ; Malaria ; Plasmodium cynomolgi/physiology ; Sporozoites ; Systems Biology ; Zoonoses
    Sprache Englisch
    Erscheinungsdatum 2022-11-24
    Erscheinungsland England
    Dokumenttyp Dataset ; Journal Article
    ZDB-ID 2775191-0
    ISSN 2052-4463 ; 2052-4463
    ISSN (online) 2052-4463
    ISSN 2052-4463
    DOI 10.1038/s41597-022-01755-y
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang